1. Home
  2. BDTX vs MED Comparison

BDTX vs MED Comparison

Compare BDTX & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$11.89

Market Cap

140.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDTX
MED
Founded
2014
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
171.9M
140.0M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
BDTX
MED
Price
$1.76
$11.89
Analyst Decision
Strong Buy
Hold
Analyst Count
7
1
Target Price
$9.67
$12.00
AVG Volume (30 Days)
2.1M
144.3K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
130.71
N/A
EPS
N/A
N/A
Revenue
N/A
$934,842,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$9.22
52 Week High
$4.94
$15.37

Technical Indicators

Market Signals
Indicator
BDTX
MED
Relative Strength Index (RSI) 33.02 44.27
Support Level N/A $10.10
Resistance Level $2.30 $12.21
Average True Range (ATR) 0.14 0.42
MACD -0.06 -0.14
Stochastic Oscillator 5.41 2.76

Price Performance

Historical Comparison
BDTX
MED

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Share on Social Networks: